Expert Opinion on Therapeutic Targets
Abbreviated title (ISO 4) | Expert Opin. Ther. Targets |
|---|---|
| Discipline | Pharmacology, therapeutics |
| Language | English |
| Publication details | |
| Publisher | |
Publication history | 1997-present |
| Frequency | Monthly |
| 5.139 | |
| Indexing | |
| ISSN |
1472-8222 (print) 1744-7631 (web) |
| LCCN | 2002243135 |
| OCLC no. | 49275520 |
| Links | |
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas.
The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs
The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.
The journal is published by Informa. The Editor in Chief of the journal is Professor Daniele Santini, University Campus Bio-Medico, Rome, Italy
Indexing
Expert Opinion on Therapeutic Targets ranks #18 of 254 in the Pharmacology & Pharmacy category in the 2014 ISI Journal Citation Reports. The journal has a 2014 impact factor of 5.139.
The journal is indexed by Chemical Abstracts, Index Medicus/MEDLINE, ISI Alerting Services™, Science Citation Index Expanded, EMBASE/Excerpta Medica